At least one household member and six healthcare workers who encountered the index case-patient are being investigated after ...

Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms ...

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the launch of its advanced ...

Seven people in contact with a patient hospitalized with bird flu also developed symptoms, the C.D.C. reported. Some are ...

The convergence of genetic engineering and artificial intelligence brings both the potential to revolutionize medicine and ...

Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With RSV ...

Respiratory Syncytial Virus (RSV) is a major health concern affecting millions each year. From the first sniffle to serious complications, understanding RSV is crucial, especially for vulnerable ...

Discover Vicebio's molecular clamp technology as it completes a $100 million series B round for its bivalent vaccine against ...

The challenge with viruses — including covid, flu and those that cause cold-like symptoms such as seasonal coronaviruses, adenoviruses, rhinoviruses, human metapneumovirus and respiratory syncytial ...

As the 2024-2025 respiratory virus season gets under way, statewide infectious disease experts urge everyone in Oregon to ...

The cold and flu season is just beginning and Helen DeVos Children’s Hospital is already seeing more cases of respiratory viruses.

Health officials in North Dakota are encouraging state residents to prepare for the upcoming respiratory illness season.